Akovaz FDA Approval History
FDA Approved: Yes (First approved April 29, 2016)
Brand name: Akovaz
Generic name: ephedrine sulfate
Dosage form: Injection
Company: Flamel Technologies
Treatment for: Hypotension
Akovaz (ephedrine sulfate) is a pressor agent administered parenterally to address clinically important hypotension in surgical settings.
Development timeline for Akovaz
| Date | Article |
|---|---|
| May 2, 2016 | Approval Flamel Technologies Receives FDA Approval of Akovaz (ephedrine sulfate) for Surgical Hypotension |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
